Infectious Diseases Archive — Page 1 of 13

September 28, 2026

California firm licenses ‘potent’ anti-measles antibodies from Vanderbilt Health for development, clinical testing

The human monoclonal antibodies were isolated from two individuals who had been infected by measles. Further development and clinical testing could lead to the first monoclonal antibody therapy against the highly infectious respiratory virus.

September 16, 2026

American Society for Microbiology honors Vanderbilt Health investigators

The ASM awards highlight the ‘strength and breadth’ of microbiology research at Vanderbilt Health — from advancing clinical diagnostics to uncovering fundamental mechanisms in the gut microbiome.

The rod-shaped pathogen C. diff must overcome a variety of threats to survive and grow in the gut. (illustration by Adobe Stock)
September 9, 2026

C. diff coordinates threat response to survive in gut

It’s critical to understand how C. diff adapts to environmental stressors in the gut in order to identify novel antimicrobial targets.

C. difficile bacteria (image courtesy of CDC/Jennifer Oosthuizen)
August 11, 2026

Vanderbilt Health evaluating vaccine for C. difficile for people 65 and older

“C. diff is one of those infections that turns a routine hospital stay or a course of antibiotics into something far more serious, and older adults bear the brunt of it.”

July 10, 2026

Study to examine metabolic complications in adults living with HIV in Nigeria   

Leveraging its expanding noncommunicable disease and HIV research portfolio in northern Nigeria, the team also plans to build local capacity in omics analysis.

July 9, 2026

Bronchiectasis Day gathering at Langford Auditorium

The Vanderbilt Health NTM and Bronchiectasis Center, a program of the Vanderbilt Lung Institute, launched in 2023. The chronic lung disease is estimated to affect 350,000 to 500,000 adults in the United States.